|
Volumn 74, Issue 1, 2002, Pages 79-84
|
Successful management of an ABO-mismatched lung allograft using antigen-specific immunoadsorption, complement inhibition, and immunomodulatory therapy
a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CD20 ANTIGEN;
COMPLEMENT COMPONENT C3B RECEPTOR;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN;
IMMUNOSUPPRESSIVE AGENT;
MONOCLONAL ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISONE;
RITUXIMAB;
THYMOCYTE ANTIBODY;
AGED;
ANTIBODY DETECTION;
ANTIBODY TITER;
ANTIGEN SPECIFICITY;
ARTICLE;
BLOOD DONOR;
BLOOD GROUP A;
BLOOD GROUP ABO INCOMPATIBILITY;
BLOOD GROUP B;
CASE REPORT;
CLINICAL FEATURE;
COMPLEMENT INHIBITION;
CONTROLLED STUDY;
DISEASE COURSE;
DRUG BLOOD LEVEL;
FOLLOW UP;
GRAFT PRESERVATION;
GRAFT REJECTION;
HISTOPATHOLOGY;
HUMAN;
IMMUNOADSORPTION;
IMMUNOMODULATION;
IMMUNOSUPPRESSIVE TREATMENT;
LUNG FIBROSIS;
LUNG TRANSPLANTATION;
MALE;
PHOTOCHEMOTHERAPY;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
RECIPIENT;
TREATMENT OUTCOME;
|
EID: 0037099349
PISSN: 00411337
EISSN: None
Source Type: Journal
DOI: 10.1097/00007890-200207150-00014 Document Type: Article |
Times cited : (58)
|
References (18)
|